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Objective: To explore the relationship between diabetes 
mellitus (DM), hyperglycemia, and adverse outcomes 
in critically ill patients with coronavirus disease 2019 
(COVID-19).
Research Design and Methods: The study popula-
tion comprised 133 patients with COVID-19 admitted 
to an intensive care unit (ICU) at an academic, urban, 
quaternary-care center between March 10th and April 8th, 
2020. Patients were categorized based on the presence of 
DM and early-onset hyperglycemia (EHG), defined as a 
blood glucose >180 mg/dL during the first two days of ICU 
admission. The primary outcome was 14-day in-hospital 
mortality; also examined were 60-day in-hospital mortality 
and the levels of C-reactive protein (CRP), interleukin 6, 
procalcitonin, and lactate. Results: Compared to non-DM 
patients without EHG, non-DM patients with EHG 
exhibited higher adjusted hazard ratios (HR) for in-hospital 
mortality at 14 days (HR 5.76, p=0.008) and 60 days (HR 
7.28, p=0.004). Non-DM patients with EHG also featured 
higher levels of mean CRP (322.3±177.7  mg/L, p=0.036), 
procalcitonin (34.75±69.33  ng/mL, p=0.028), and lactate 
(2.7±2.1 mmol/L, p=0.023). Conclusions: In patients with 
critical illness from COVID-19, those without DM with 
EHG were at greatest risk of 14-day and 60-day in-hospital 
mortality. The limitations of our study include its retro-
spective design, and relatively small cohort. However, our 
results raise the possibility that the combination of el-
evated glucose and lactate may identify a specific cohort 
of individuals at high mortality risk from COVID-19, and 
suggest that glucose testing and control are important in 
individuals with COVID-19, even in those without pre-
existing diabetes.
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Introduction: The coronavirus disease global pandemic 
led to national lockdown in the United Kingdom on 23rd 
March 2020. We compared the glycaemic control of chil-
dren and adolescents with Type 1 diabetes (T1DM) at 
Doncaster & Bassetlaw Teaching Hospitals in the 12 weeks 
prior to the lockdown, to the 12 weeks following lockdown. 
Methods: HbA1c result 3  months following lockdown 
was compared to the last HbA1C prior to lockdown. Data 
from Continuous Glucose Monitors (CGMs), Flash Glucose 
Systems (FGS) and those performing Self-Monitoring of 
Blood Glucose (SMBG) were compared alongside changes 
to patient contact that occurred. Results: In 264 patients 
under 20 years of age across both hospitals in the Trust, 
face-to-face consultations decreased (245 vs 151, 39%), and 
remote consultations increased (1751 vs 2269, 30%) (χ 2 
p<0.001). Excluding those within a year of diagnosis, 122 
had paired HbA1c results, and 80 had more than 70% of 
glucose monitoring data available. HbA1c levels decreased 
(67.4  mmol/mol vs 61.3  mmol/mol, p<0.001) and glucose 
monitoring data showed lower mean glucose after lockdown 
(9.7mmol/L vs 9.5mmol/L, p=0.034) with lower standard 
deviation (4.4mmol/L vs 4.2mmol/L, p<0.001). Proportion 
of time in range (3.9mmol/L to 10mmol/L) increased (n=47, 
55.2% vs 58.0%, p=0.017), with no change to time below 
range (4.8% vs 5.0%, p=0.495). Conclusion: Glycaemic 
control improved in the 12 weeks following national lock-
down. This demonstrates the difficulties faced by patients 
and carers managing T1DM around school pressures, meals 
away from home, social life and peer pressure. Increased 
remote contact with patients with T1DM has not been det-
rimental to glycaemic control.
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Introduction: During the COVID-19 pandemic, lockdown 
measures were implemented with large impact on lifestyle 
behaviors and well-being of children (including adolescents). 
The impact on children with severe obesity, who plausibly 
are at even larger risk, has not yet been described. Aim of 
this study was to investigate the impact of COVID-19 lock-
down on eating behaviors, physical activity, screen time 
and quality of life (QoL) of children with severe obesity. 
Methods: In this mixed-methods study, questionnaires 
and semi-structured telephone interviews were used to in-
vestigate impact of COVID-19 during the first wave in the 
Netherlands (April 2020)  on children with severe obesity 
(adult BMI-equivalent ≥35kg/m2) treated at our obesity 
center. The Dutch Eating Behavior Questionnaire - Child, 
Pediatric Quality of Life Inventory, and Dutch Physical 
Activity Questionnaire were filled out by their families 
pre-pandemic and during lockdown. Changes over time 
in percentile scores, weekly physical activity and screen 
time were assessed. Qualitative analyses were performed 
according to the Grounded Theory. Results: We included 
83 families, of which 75 participated in the interviews. 
Their children’s characteristics were mean age 11.5 years 
(SD 4.6), 52% female, mean BMI SD score 3.8 (SD 1.0), 
indicating severe obesity. On group level, no changes in 
scores for emotional, restrained, external eating, and QoL 
nor in screen time were observed (Δ scores +9.2, +3.9, +0.3; 
and +3.0, respectively; -0.3  hr/wk; all p>0.05). Weekly 
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